Cargando…
The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study
INTRODUCTION: Hyperglycaemia occurs frequently in the critically ill, affects outcome adversely, and is exacerbated by enteral feeding. Furthermore, treatment with insulin in this group is frequently complicated by hypoglycaemia. In healthy patients and those with type 2 diabetes, exogenous glucagon...
Autores principales: | Deane, Adam M, Chapman, Marianne J, Fraser, Robert JL, Burgstad, Carly M, Besanko, Laura K, Horowitz, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717426/ https://www.ncbi.nlm.nih.gov/pubmed/19439067 http://dx.doi.org/10.1186/cc7874 |
Ejemplares similares
-
Exogenous glucagon-like peptide 1: a potentially novel therapy for the management of hyperglycaemia in the critically ill
por: Deane, A, et al.
Publicado: (2009) -
Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
por: Deane, Adam M, et al.
Publicado: (2011) -
Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
por: Chapman, M, et al.
Publicado: (2011) -
The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
por: Lee, Michael Y., et al.
Publicado: (2013) -
The therapeutic potential of a venomous lizard: the use of glucagon-like peptide-1 analogues in the critically ill
por: Deane, Adam M, et al.
Publicado: (2010)